Americans for Safe Access

Last updated
Americans for Safe Access
AbbreviationASA
Formation2002;22 years ago (2002)
Founded at California
Headquarters Washington, D.C.
Membership250,000
LeaderSteph Sherer
Website safeaccessnow.org

Americans for Safe Access (ASA), is a Washington, D.C., based advocacy organization working to ensure safe and legal access to medical cannabis [1] [2]

Related Research Articles

<span class="mw-page-title-main">Medical cannabis</span> Cannabis sativa L. (marijuana; hemp) used medicinally

Medical cannabis, medicinal cannabis or medical marijuana (MMJ) refers to cannabis products and cannabinoid molecules that are prescribed by physicians for their patients. The use of cannabis as medicine has a long history, but has not been as rigorously tested as other medicinal plants due to legal and governmental restrictions, resulting in limited clinical research to define the safety and efficacy of using cannabis to treat diseases.

<span class="mw-page-title-main">Ed Rosenthal</span> American horticulturist, author, publisher, and cannabis grower

Edward "Ed" Rosenthal is an American horticulturist, author, publisher, and Cannabis grower known for his advocacy for the legalization of marijuana use. He served as a columnist for High Times Magazine during the 1980s and 1990s. He was arrested in 2002 for cultivation of cannabis by federal authorities, who do not recognize the authority of states to regulate the use of medical marijuana. He was convicted in federal court, but the conviction was overturned on appeal. Rosenthal was subsequently convicted again, but was not re-sentenced, since his original sentence had been completed.

<span class="mw-page-title-main">Removal of cannabis from Schedule I of the Controlled Substances Act</span> Proposed changes to the legal status of cannabis in U.S. federal law

In the United States, the removal of cannabis from Schedule I of the Controlled Substances Act, the category reserved for drugs that have "no currently accepted medical use", is a proposed legal and administrative change in cannabis-related law at the federal level. After being proposed repeatedly since 1972, the U.S. Department of Justice initiated 2024 rulemaking to reschedule cannabis to Schedule III of the Controlled Substances Act. The majority of 2024 public comments supported descheduling, decriminalizing, or legalizing marijuana at the federal level.

Alejandro Abellan is a Canadian film and television actor and Cannabis Advocate.

<span class="mw-page-title-main">Legal history of cannabis in the United States</span>

In the United States, increased restrictions and labeling of cannabis as a poison began in many states from 1906 onward, and outright prohibitions began in the 1920s. By the mid-1930s cannabis was regulated as a drug in every state, including 35 states that adopted the Uniform State Narcotic Drug Act. The first national regulation was the Marihuana Tax Act of 1937.

The Rohrabacher–Farr amendment is legislation introduced by U.S. Representative Maurice Hinchey in 2001, prohibiting the Justice Department from spending funds to interfere with the implementation of state medical cannabis laws. It passed the House in May 2014 after six previously failed attempts, becoming law in December 2014 as part of an omnibus spending bill. The passage of the amendment was the first time either chamber of Congress had voted to protect medical cannabis patients, and is viewed as a historic victory for cannabis reform advocates at the federal level. The amendment does not change the legal status of cannabis, however, and must be renewed each fiscal year in order to remain in effect.

<span class="mw-page-title-main">Veterans for Medical Cannabis Access</span> American cannabis advocacy group

Veterans for Medical Cannabis Access (VMCA), which was founded as Veterans for Medical Marijuana Access (VMMA) reflecting the pejorative word "marijuana", is an Elliston, Virginia-based non-profit service organization designed to assist American veterans who wish to be able to use marijuana for medical purposes with a doctor's recommendation. VMCA works towards the freedom for veterans to discuss the medical use of marijuana with their doctors without the risk of reprisal.

<span class="mw-page-title-main">Cannabis in the United States</span>

The use, sale, and possession of cannabis containing over 0.3% THC by dry weight in the United States, despite laws in many states permitting it under various circumstances, is illegal under federal law. As a Schedule I drug under the federal Controlled Substances Act (CSA) of 1970, cannabis containing over 0.3% THC by dry weight is considered to have "no accepted medical use" and a high potential for abuse and physical or psychological dependence. Cannabis use is illegal for any reason, with the exception of FDA-approved research programs. However, individual states have enacted legislation permitting exemptions for various uses, including medical, industrial, and recreational use.

<span class="mw-page-title-main">Medical cannabis in the United States</span>

In the United States, the use of cannabis for medical purposes is legal in 38 states, four out of five permanently inhabited U.S. territories, and the District of Columbia, as of March 2023. Ten other states have more restrictive laws limiting THC content, for the purpose of allowing access to products that are rich in cannabidiol (CBD), a non-psychoactive component of cannabis. There is significant variation in medical cannabis laws from state to state, including how it is produced and distributed, how it can be consumed, and what medical conditions it can be used for.

Americans for Safe Access v. Drug Enforcement Administration was a case in which the U.S. Court of Appeals for the D.C. Circuit held that the DEA's denial of a petition by plaintiff Americans for Safe Access for removal of cannabis from Schedule I of the Controlled Substances Act survives review under the deferential arbitrary and capricious standard. 21 U.S.C. § 812(b)(1)(B) requires that cannabis be found to have no "currently accepted medical use" in order to remain in Schedule I. This DEA, pursuant to regulations that the court had approved in Alliance for Cannabis Therapeutics v. DEA, interpreted this to require "adequate and well-controlled studies proving efficacy" in order for cannabis to be removed from Schedule I. The court deferred to the agency's interpretation and found that substantial evidence supported the DEA's determination that such studies do not exist. This case was the third attempt to get the D.C. Circuit to order that cannabis be rescheduled.

<span class="mw-page-title-main">1998 Washington, D.C., Initiative 59</span> Ballot measure in Washington, D.C., legalizing medical cannabis

Initiative 59 was a 1998 ballot initiative in Washington, D.C., that sought to legalize medical cannabis. The short title of the initiative was "Legalization of Marijuana for Medical Treatment Initiative of 1998". Though the initiative passed with 69% of the vote in November 1998, its implementation was delayed by Congress's passage of the Barr Amendment, which prohibited DC from using its funds in support of the program. This Amendment delayed the start of the medical marijuana program until it was effectively overturned in 2009, with the first DC customer legally purchasing medical cannabis at a dispensary in the District in 2013.

<span class="mw-page-title-main">Cannabis in Puerto Rico</span>

Cannabis in Puerto Rico is illegal for recreational use. Legislation to ban cannabis was passed in 1932, and legislation to legalize medical use was passed in 2017. Although the medical use of cannabis is permitted, smoking it is prohibited.

Doctors for Drug Policy Reform, or D4DPR is a 501(c)(3) non-profit organization that serves as a global voice for licensed health professionals and scientists advocating for evidence-based drug policies and best practices that advance public health, reduce stigma, and minimize harm. D4DPR leverage the expertise, compassion, and influence of licensed health professionals to enact changes in drug policy necessary to improve public health, human rights, social justice, and consumer protections. D4DPR, formerly DFCR, was founded in 2015 by David L. Nathan. In 2021, Dr. Bryon Adinoff, an addictionologist, researcher, and editor-in-chief of the American Journal of Drug and Alcohol Abuse succeeded Nathan to become D4DPR's second president.

Patients Out of Time (POT) is an American medical cannabis nonprofit organization and patients rights group, established in 1995.

Cannabis product testing is a form of product testing analyzes the quality of cannabis extracts, edibles, and THC and CBD levels in an emergent consumer market eager to sell adult use products. Analytical chemistry and microbiology laboratories are important entities in consumer protection. These labs not only determine the condition and viability of cannabinoids, water content, heavy metals, pesticides, terpenes, yeast, but also the presence of mold, mycotoxins, and solvents. These laboratories emerged when advocates of cannabis testing raised concerns about potential contaminants.

<span class="mw-page-title-main">SAFE Banking Act</span> U.S bill regarding cannabis businesses and banking

The SAFE Banking Act, officially H.R. 1595, full title Secure and Fair Enforcement (SAFE) Act, also referred to as the SAFE Banking Act of 2019, and as of 2023 the Secure and Fair Enforcement Regulation (SAFER) Banking Act, is proposed legislation regarding disposition of funds gained through the cannabis industry in the United States.

<span class="mw-page-title-main">Impact of the COVID-19 pandemic on the cannabis industry</span> Impact of COVID-19

The COVID-19 pandemic had a significant impact on the cannabis industry. Investor's Business Daily said the industry was affected as "customers stock up on prescriptions and recreational customers load up on something to make the lockdown a little more mellow or a little less boring".

U.S. President Joe Biden stated in February 2021 that his administration will pursue cannabis decriminalization as well as seek expungements for people with prior cannabis convictions. As of October 2022, Biden pardoned thousands of people convicted of marijuana possession under federal law. However, according to the Marshall Project, nobody was released from prison as a result of the October 2022 pardons, as no federal inmates were incarcerated for simple marijuana use at the time.

References

  1. "About". Americans for Safe Access. Retrieved June 2, 2017.
  2. "'Ridiculous' price of medical marijuana leaves patients scrambling". NBC News. 2021-07-17. Retrieved 2024-11-03.